Fig. 4From: Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 casesA Initial and revised pathologists’ consensus of subtype. B Initial and revised concordance rates of subtype among pathologists (ER: estrogen receptor, HER2: human epidermal growth factor receptor 2, PR: progesterone receptor)Back to article page